C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,129 | -104,994 | -84,508 | -52,342 | -26,322 |
| Depreciation Amortization | -685 | -783 | -348 | -293 | -327 |
| Accounts receivable | -482 | 701 | -3,440 | 901 | -4,926 |
| Accounts payable and accrued liabilities | -85 | -468 | 4 | 889 | -645 |
| Other Working Capital | -8,272 | -29,282 | -22,601 | -6,571 | -13,818 |
| Other Operating Activity | 4,709 | 36,132 | 34,344 | 12,074 | 12,753 |
| Operating Cash Flow | $-29,944 | $-98,694 | $-76,549 | $-45,342 | $-33,285 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -40,812 | -227,074 | -94,003 | -47,320 | -25,640 |
| PPE Investments | -64 | -607 | -596 | -185 | N/A |
| Sale Of Investment | 57,029 | 219,080 | 166,731 | 115,551 | 54,765 |
| Investing Cash Flow | $16,153 | $-8,601 | $72,132 | $68,046 | $29,125 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 606 | 126,318 | 7,633 | 0 | N/A |
| Common Stock Repurchased | -200 | -193 | -179 | -155 | -155 |
| Other Financing Activity | 56 | 274 | 273 | 109 | 109 |
| Financing Cash Flow | $462 | $126,399 | $7,727 | $-46 | $-46 |
| Beginning Cash Position | 78,046 | 58,942 | 58,942 | 58,942 | 58,942 |
| End Cash Position | 64,717 | 78,046 | 62,252 | 81,600 | 54,736 |
| Net Cash Flow | $-13,329 | $19,104 | $3,310 | $22,658 | $-4,206 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,944 | -98,694 | -76,549 | -45,342 | -33,285 |
| Capital Expenditure | -64 | -607 | -596 | -185 | N/A |
| Free Cash Flow | -30,008 | -99,301 | -77,145 | -45,527 | -33,285 |